Literature DB >> 8674169

Echocardiographic and radionuclide pulmonary blood flow patterns after transcatheter closure of patent ductus arteriosus.

H Dessy1, J P Hermus, F van den Heuvel, H Y Oei, E P Krenning, J Hess.   

Abstract

BACKGROUND: Transcatheter occlusion of patent ductus arteriosus (PDA) has been associated with protrusion of the occluder device into the left pulmonary artery (LPA). This study was conducted to evaluate the significance of occluder protrusion and its implications for potential obstruction of the LPA and associated decrease of left lung perfusion. METHODS AND
RESULTS: Fifty-two patients underwent successful transcatheter PDA occlusion over a period of 5 years. In this study, 49 were reexamined between March and June 1995. In addition to clinical and echocardiographic examination, lung scintigraphy was performed. Protrusion into the LPA was present in 5 of 49 patients (10%). In these patients, maximal flow velocity in the LPA was significantly (P < .01) increased. Decreased left lung perfusion, defined as < 40% of total pulmonary blood flow, was found in 7 of 49 patients (14%). Although mean left pulmonary perfusion was significantly (P = .02) decreased in patients with protrusion, there was considerable overlap with patients without protrusion, and only a weak correlation was found (r = -.35, P = .01) between flow-velocity and left lung perfusion.
CONCLUSIONS: Our results demonstrate that protrusion of the device in the LPA is an infrequent finding. If present, it is associated with increased maximal flow velocity in the LPA and diminished left lung perfusion. However, echocardiography and lung scintigraphy are weakly correlated: Increased maximal blood flow velocities in the proximal LPA proved to be a poor indicator or impaired left lung perfusion. Also, decreased perfusion occurs in the absence of echocardiographic evidence of device protrusion.

Entities:  

Mesh:

Year:  1996        PMID: 8674169     DOI: 10.1161/01.cir.94.2.126

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Catheter interventions in congenital heart disease without regular catheterization laboratory equipment: the chain of hope experience in Rwanda.

Authors:  John Senga; Emmanuel Rusingiza; Joseph Mucumbitsi; Agnès Binagwaho; Bert Suys; Christine Lys; Karlien Carbonez; Caroline Ovaert; Thierry Sluysmans
Journal:  Pediatr Cardiol       Date:  2012-05-27       Impact factor: 1.655

Review 2.  [Interventions in congenital heart disease and their sequelae in adults].

Authors:  A A Schmaltz; U Neudorf; S Sack; O Galal
Journal:  Herz       Date:  1999-06       Impact factor: 1.443

3.  Lung perfusion studies after detachable coil occlusion of persistent arterial duct.

Authors:  N Sreeram; M Tofeig; K P Walsh; P Hutter
Journal:  Heart       Date:  1999-06       Impact factor: 5.994

4.  Differential pulmonary perfusion scan after percutaneous occlusion of the patent ductus arteriosus: one-decade consecutive longitudinal study from a single institution.

Authors:  Euloge Kouadio Kramoh; Joaquim Miró; Jean-Luc Bigras; Sophie Turpin; Raymond Lambert; Chantal Lapierre; Weidong Jin; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2008-04-17       Impact factor: 1.655

5.  Preclosure pressure gradients predict patent ductus arteriosus patients at risk for later left pulmonary artery stenosis.

Authors:  Srinath T Gowda; Shelby Kutty; Makram Ebeid; Athar M Qureshi; Sarah Worley; Larry A Latson
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

6.  The Amplatzer duct occluder for PDA closure: indications, technique of implantation and clinical outcome.

Authors:  W Boehm; M Emmel; N Sreeram
Journal:  Images Paediatr Cardiol       Date:  2007-04

7.  Inflow-weighted pulmonary perfusion: comparison between dynamic contrast-enhanced MRI versus perfusion scintigraphy in complex pulmonary circulation.

Authors:  Yi-Ru Lin; Shang-Yueh Tsai; Teng-Yi Huang; Hsiao-Wen Chung; Yi-Luan Huang; Fu-Zong Wu; Chu-Chuan Lin; Nan-Jing Peng; Ming-Ting Wu
Journal:  J Cardiovasc Magn Reson       Date:  2013-02-28       Impact factor: 5.364

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.